Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma-Reference-Cited by-同舟云学术

Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma

Published:2014-02-24 Issue:7 Volume:69 Page:638-647
ISSN:0040-6376
Container-title:Thorax
language:en
Short-container-title:Thorax

Author:

Sage Elizabeth K,Kolluri Krishna K,McNulty Katrina,Lourenco Sofia Da Silva,Kalber Tammy L,Ordidge Katherine L,Davies Derek,Gary Lee Y C,Giangreco Adam,Janes Sam M

Publisher

BMJ

Subject

Pulmonary and Respiratory Medicine

Reference37 articles.

1. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province;Wagner;Br J Ind Med,1960

2. Mesothelioma Register;Executive HaS

3. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma;Vogelzang;J Clin Oncol,2003

4. The MARS trial: mesothelioma and radical surgery;Treasure;Interact Cardiovasc Thorac Surg,2006

5. Defective core-apoptosis signalling in diffuse malignant pleural mesothelioma: opportunities for effective drug development;Fennell;Lancet Oncol,2004

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stroma;Cell Reports Medicine;2024-08

2. Biological differences between adult and perinatal human mesenchymal stromal cells and their impact on the manufacturing processes;Cytotherapy;2024-05

3. Current progress in engineered and nano-engineered mesenchymal stem cells for cancer: From mechanisms to therapy;Biomedicine & Pharmacotherapy;2023-11

4. Current approaches to the genetic modification of mesenchymal stromal cells to increase their therapeutic efficacy;Genes & Cells;2023-10-03

5. Nanoghosts: Harnessing Mesenchymal Stem Cell Membrane for Construction of Drug Delivery Platforms Via Optimized Biomimetics;Small;2023-08-31